On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.
"So we built the seatbelts before the car, so to speak, wherein we did a project to figure out ways to biocontain these organisms....
"What can I contribute that my doctor can't contribute? And that's a real 'a-ha' moment when we share with them how they're the experts...
"Patients have already been exposed to these large language models (LLMs). Yes, they are aware of the risks, but they are also very aware...